Skip to content

Biogen BIIB Price / earnings

Price / earnings at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
19.8×-16.3×
Eli Lilly logo
Eli LillyLLY
32.5×-34.3×
Royalty Pharma logo
Royalty PharmaRPRX
24.8×+12.5×
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
17×-6.2×
Amgen logo
AmgenAMGN
24.3×-3.9×
Incyte logo
IncyteINCY
13.1×-538×

Other financials

Income statement

See full
Revenue$2.5B+1.9%
Gross profit$1.8B+0.8%
Net income$319.5M+32.9%
EPS (diluted)$2.15+31.1%

Balance sheet

See full
Cash & equivalents$3.4B+30.2%
Total debt$6.6B+34.7%
Total equity$18.7B+9.9%
Total assets$29.5B+5.2%

Cash flow

See full
Operating cash flow$645.5M+149%
CapEx$51.2M+38.0%
Free cash flow$594.3M+167%

Valuation

See full
Market cap$29.33B+34.3%
Enterprise value$32.51B+34.9%
P/S+0.7×

Profitability

See full
Gross margin75.5%-0.1pp
Operating margin22.9%
Net margin14.3%-0.8pp

Returns & leverage

See full
Return on equity8%-1.2pp
Debt / equity0.4×+0.1×
Current ratio3.1×+1.6×

Where this comes from

Calculated from Biogen’s reported figures.

Based on the most recent quarter.

The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biogen's price / earnings?
Biogen (BIIB) reported price / earnings of 18.9× in Q1 2026.
How has Biogen's price / earnings changed year-over-year?
Biogen's price / earnings increased by 39.9% year-over-year, from 13.5× to 18.9×.
What is the long-term trend for Biogen's price / earnings?
Over 4 years (2021 to 2025), Biogen's price / earnings has grown at a -10.5% compound annual growth rate (CAGR), from 89.7× to 57.6×.
What does price / earnings mean?
How many dollars investors pay for each dollar of the company's annual profit.
How do you interpret price / earnings?
Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
How does price / earnings compare across companies?
Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.